Learning Objectives:
1. Recognize clinical features of STING-associated vasculopathy.
2. Explain the cGAS-STING pathway and its role in autoimmunity.
3. Explain the cGAS-STING pathway and its role in antiviral immunity.
Session date:
03/10/2020 - 8:30am to 9:30am CDT
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Jonathan Miner, M.D., Ph.D.

Facebook
X
LinkedIn
Forward